Literature DB >> 17589636

Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure.

Luiz Antônio Brito Arruda Vasconcelos1, Eros Antônio de Almeida, Luiz Felipe Bachur.   

Abstract

OBJECTIVES: To verify the clinical alterations and, in particular, hepatic laboratory alterations in patients in each of the heart failure (HF) functional classes.
METHODS: The clinical and laboratory data--alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AP), gamma-glutamyl transpeptidase (GGT), bilirubin and coagulogram--of 50 patients admitted in 2002 to a tertiary hospital with the diagnosis of heart failure were researched by means of a cross sectional study. The patients were separated in accordance with their HF class and their data were compared statistically. Patients with hepatopathy of any etiology were excluded.
RESULTS: Analysis of the mean transaminase values revealed a significant increase only for the Class IV patients. On the other hand, alkaline phosphatase and GGT presented a progressive increase in accordance with the HF class.
CONCLUSION: HF is characterized by a progressive cholestatic profile of laboratory alterations, while transaminase values are only elevated in advanced HF. It is of utmost importance to understand these alterations in order to avoid unnecessary hepatic investigations in individuals with heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589636     DOI: 10.1590/s0066-782x2007000500015

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  12 in total

1.  Serum gamma-glutamyl transferase and risk of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Thomas J Wang; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

Review 2.  Congestive hepatopathy: Differentiating congestion from fibrosis.

Authors:  Alexander Lemmer; Lisa VanWagner; Daniel Ganger
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-01-02

3.  Liver diseases in heart failure.

Authors:  Majid Maleki; Farveh Vakilian; Ahmad Amin
Journal:  Heart Asia       Date:  2011-01-01

Review 4.  Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.

Authors:  Alexander Lemmer; Lisa B VanWagner; Daniel Ganger
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

5.  Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.

Authors:  Aalap Chokshi; Faisal H Cheema; Kenneth J Schaefle; Jeffrey Jiang; Elias Collado; Khurram Shahzad; Tuba Khawaja; Maryjane Farr; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2012-03-27       Impact factor: 10.247

6.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

Review 7.  Cardiohepatic syndrome: liver injury in decompensated heart failure.

Authors:  Said Laribi; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 8.  Relationship between Heart Disease and Liver Disease: A Two-Way Street.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

Review 9.  Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function.

Authors:  Ilhuicamina Daniel Limón; Isael Angulo-Cruz; Lesli Sánchez-Abdon; Aleidy Patricio-Martínez
Journal:  Front Neurosci       Date:  2021-01-27       Impact factor: 4.677

10.  Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure.

Authors:  Bożena Szyguła-Jurkiewicz; Michał Zakliczyński; Michał Ploch; Mateusz Mościński; Robert Partyka; Romuald Wojnicz; Marian Zembala; Lech Poloński
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.